{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:13:56Z","timestamp":1791994436989,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.neurobiolaging.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T22:29:21Z","timestamp":1537223361000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"special_numbering":"C","title":["Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4862-4221","authenticated-orcid":false,"given":"Cinzia","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-8543","authenticated-orcid":false,"given":"Michele","family":"Romoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Farotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Eusebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Siliquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Nardi","family":"Cesarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4505-2600","authenticated-orcid":false,"given":"Andrea","family":"Romigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola B.","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0326-5509","authenticated-orcid":false,"given":"Paolo","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13375","article-title":"Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study","volume":"24","author":"Bedetti","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1528-1167.2009.02285.x","article-title":"Recommendation for a definition of acute symptomatic seizure","volume":"51","author":"Beghi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neurobiolaging.2016.08.025","article-title":"Epilepsy, amyloid-\u03b2, and D1 dopamine receptors: a possible pathogenetic link?","volume":"48","author":"Costa","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3233\/JAD-150096","article-title":"Epileptic prodromal Alzheimer\u2019s disease, a retrospective study of 13 new cases: expanding the spectrum of Alzheimer\u2019s disease to an epileptic variant?","volume":"52","author":"Cretin","year":"2016","journal-title":"J.\u00a0Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.eplepsyres.2017.11.015","article-title":"The new definition and classification of seizures and epilepsy","volume":"139","author":"Falco-Walter","year":"2018","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE Official Report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neurobiolaging.2017.05.017","article-title":"EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects","volume":"57","author":"Gouw","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935\u20131984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1528-1167.2007.01435.x","article-title":"Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy","volume":"49","author":"Hermann","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib13","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jamaneurol.2016.6091","article-title":"Association between childhood-onset epilepsy and amyloid burden 5 decades later","volume":"74","author":"Joutsa","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12017-009-8076-z","article-title":"Epileptic seizures in AD patients","volume":"12","author":"Larner","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JAD-150342","article-title":"Validation of the Erlangen score algorithm for the prediction of the development of dementia due to Alzheimer\u2019s disease in pre-dementia subjects","volume":"48","author":"Lewczuk","year":"2015","journal-title":"J.\u00a0Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib17","first-page":"1","article-title":"Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the consensus of the Task Force on biological markers in psychiatry of the World Federation of Societies of Biological Psychiatry","volume":"2975","author":"Lewczuk","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neurobiolaging.2016.01.007","article-title":"Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer\u2019s disease","volume":"40","author":"Liguori","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF00294177","article-title":"Senile plaques in temporal lobe epilepsy","volume":"87","author":"Mackenzie","year":"1994","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib21","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR)","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0719-y","article-title":"Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group","volume":"14","author":"Perneczky","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0079-6123(02)35008-8","article-title":"Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy","volume":"135","author":"Pitk\u00e4nen","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib26","first-page":"173","article-title":"Review Is epilepsy a progressive disorder?","volume":"1","author":"Pitk\u00e4nen","year":"2002","journal-title":"Prospects New Ther."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib27","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN internal Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2017.00360","article-title":"Recurrent epileptic auras as a presenting symptom of Alzheimer\u2019s disease","volume":"8","author":"Sarkis","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib30","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib32","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1046\/j.1471-4159.1994.63051872.x","article-title":"Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity","volume":"63","author":"Sheng","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib33","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3892\/mmr.2014.1977","article-title":"Expression of \u03b2-amyloid precursor protein in refractory epilepsy","volume":"9","author":"Sima","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neurobiolaging.2018.09.006_bib34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018303294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458018303294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T10:27:11Z","timestamp":1543487231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458018303294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":34,"alternative-id":["S0197458018303294"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.006","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}